Healthcare company PENTAX Medical reported on Wednesday the receipt of US FDA 510(k) clearance for its IMAGINA Endoscopy System for gastrointestinal (GI) procedures at ambulatory surgery centres (ASCs) across the US.

According to PENTAX Medical, the IMAGINA System offers practitioners a modern user interface and unique endoscope design to provide excellent visualisation, improve the operator experience and positively influence long-term patient care costs.

Features include a sleek, touch-screen LCD interface on the processor and brilliant images in crisp 1080p resolution, all while providing greater cost predictability by eliminating the need for expensive periodic bulb replacements. It also includes PENTAX i-SCAN, a real-time, digital image enhancement technology that provides the user with an enhanced view of the texture of the mucosal surface and the blood vessels.

ASCs are positioned to perform fundamental GI procedures efficiently and cost-effectively, leading to increases in procedure volume. However, rising capital equipment costs and declining reimbursement rates present a significant challenge for clinics looking to provide quality care at a lower cost per procedure.

PENTAX Medical developed the IMAGINA Endoscopy System to meet the needs of ASCs and eliminate the trade-off between cost and quality care.